IceCure shareholders approve meeting agenda after adjournment
No actual results were disclosed, so the filing cannot be compared with the prior FY2026 guidance midpoint. At the adjourned Annual and Special General Meeting, shareholders approved the agenda items described in the October 5, 2026 proxy statement after a quorum was present. The filing does not provide proposal-level voting results.
Key takeaways
Meeting date: IceCure convened its Annual and Special General Meeting on November 2, 2026.
Initial adjournment: The November 2 meeting was initially adjourned from 5:00 p.m. because a required quorum was not present.
Reconvening: The meeting was held at 6:30 p.m. Israel time with a quorum present.
Approval: Shareholders approved the agenda items described in the proxy statement previously furnished as Exhibit 99.2 on October 5, 2026.
Disclosure scope: The filing does not enumerate the approved proposals or provide vote counts, financial results, or guidance updates.
Primary source
TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.
Open SEC filingFollow ICCM in real time
Get material earnings, filing, IR, and earnings-call alerts by email.